Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals.

We are delighted to share our new paper:

Challenges in management of pediatric chronic myeloid leukemia (pCML) in the low- and middle income countries (LMICs’): Insights from an International CML Foundation (iCMLf) Multi National Study
Roy Moulik N et al. Pediatr Hematol Oncol, January 2024 (epub ahead of print)

The survey sheds light on patient, physician, and infrastructure challenges, urging the need for context-specific guidelines, advocacy for continuous TKI access, and improvements in diagnostic resources.

Other latest publications include:

• Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia
  Behrens YL et al. Haematologica, March 2024 – open access publication
• Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: Influence of demographic, pharmacological, and genetic factors in the German CML-PAED Cohort
  Stiehler S et al. Haematologica, March 2024 (epub ahead of print) – open access publication
  
• Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patient with chronic myeloid leukemia
  Abdallah AM et al. Leuk Lymphoma, March 2024 (epub ahead of print)
• Chronic spontaneous urticarial as the presenting factor in a paediatric case of chronic myeloid leukemia
  Sutton KM et al. Pediatr Blood Cancer, March 2024
• Bosutinib in resistant and intolerant pediatric patients with chronic phase chronic myeloid leukemia: Results from the Phase I part of Study ITCC054/COG AMML1921
  Brivio E et al. J Clin Oncol, March 2024 – open access publication
• A 3-year old with chronic myeloid leukemia
  Coty-Fatall Z & Richardson A. Blood, February 2024
• Reduced-intensity therapy for relapsed Philadelphina chromosome-positive leukemia
  Nagasawa S et al. Pediatr Blood Cancer, February 2024
• Pediatric chronic myeloid leukemia P190 variant with IgA vasculitis: Rare association – case report
  Shah K et al. Pediatr Blood Cancer, January 2024
• Bosutinib: Pediatric first approval - Review
  Hoy SM. Paediatr Drugs, December 2023 (epub ahead of print)
• Skin reactions to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia - Review
  Toker M et al. Pediatr Dermatol, December 2023 (epub ahead of print)
• Treatment and follow-up of children with chronic myeloid leukemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era – Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort
  Roy Moulik N et al. Br J Haematol, December 2023 (epub ahead of print)

Search here for more publications on pediatric CML